MUCOPOLYSACCHARIDOSIS III-B

Clinical trials for MUCOPOLYSACCHARIDOSIS III-B explained in plain language.

Never miss a new study

Get alerted when new MUCOPOLYSACCHARIDOSIS III-B trials appear

Sign up with your email to follow new studies for MUCOPOLYSACCHARIDOSIS III-B, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet finished but already full! 1

New hope for rare childhood brain disease

Disease control Recruiting now

This early-stage study is testing a new drug called JR-446 in children under 18 with a rare, serious genetic disorder called MPS IIIB (Sanfilippo syndrome type B). The main goals are to check if the drug is safe and to see how it affects the body. Researchers will enroll about 10…

Matched conditions: MUCOPOLYSACCHARIDOSIS III-B

Phase: PHASE1, PHASE2 • Sponsor: JCR Pharmaceuticals Co., Ltd. • Aim: Disease control

Last updated Mar 19, 2026 14:56 UTC

MUCOPOLYSACCHARIDOSIS III-B

Get alerted when new MUCOPOLYSACCHARIDOSIS III-B trials appear

New hope for rare childhood brain disease